Metaglip
Formulated to manage type 2 diabetes mellitus, this combined therapy is utilized to support blood glucose control and to mitigate glycemic fluctuations.
- Category
- Diabetes Management
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Tablet
- Strengths
- 2.5/500 · 5/500mg
Metaglip details
- Condition
- Type 2 Diabetes Mellitus
- Alternative names
- Glucovance
- Therapeutic class
- Biguanide; Sulfonylurea
- Pharmacological class
- Biguanide; Sulfonylurea
- Precautions and warnings
- monitor blood glucose levels; risk of lactic acidosis; monitor for hypoglycaemia
- Minor side effects
- nausea; diarrhoea; abdominal discomfort
- Moderate side effects
- hypoglycaemia; dizziness; weight gain
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Bristol-Myers Squibb
- Onset Time
- 1–2 hours
- Duration
- 12–24 hours
- Storage instructions
- Store at room temperature.
- Drug interactions
- alcohol; cimetidine; diuretics; corticosteroids
- Age restrictions
- Not for use in children.
- Pregnancy and breastfeeding
- Pregnancy: Insulin is preferred. Breastfeeding: Not recommended.
Contraindications
type 1 diabetes; diabetic ketoacidosis; severe renal impairment; severe hepatic impairment
Serious side effects
lactic acidosis, requires immediate medical attention; anaphylaxis, requires immediate medical attention
Patient summary
Formulated to manage type 2 diabetes mellitus, this combined therapy is utilized to support blood glucose control and to mitigate glycemic fluctuations.
Mechanism of action
Metformin reduces hepatic glucose production and increases insulin sensitivity, while glipizide stimulates pancreatic insulin secretion, providing a dual approach to glycemic management.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Metaglip
Metaglip contains glipizide and metformin, which are used together for the management of Type 2 Diabetes Mellitus. This medication combination is also sold under the brand name Glucovance. Manufactured by Bristol-Myers Squibb, it is supplied as a tablet in strengths of 2.5/500mg and 5/500mg.
Buying Metaglip online
Metaglip is registered across 13 markets, including Malaysia, the Philippines and Indonesia, with availability in Taiwan, South Korea and Japan. Since generic glipizide and metformin, often produced in India, offers a more affordable price point than the original brand, many expats and those in remote areas rely on these consistent supplies. It remains one of our frequently ordered products for glucose management, available for delivery across the region.